The coronavirus vaccine was developed faster than any vaccine in history. It took just 332 days from the first sequencing of the virus genome to the first vaccines given to the public.
The new rapid test is available without a prescription, but only 20 million are set to be sold by the middle of next year.
Ellume/AP
Zoë McLaren, University of Maryland, Baltimore County
A new over-the-counter COVID-19 test has been authorized by the FDA. Though it can be used to test people with and without symptoms, moderate cost and limited production mean it isn't a game-changer.
Although monetary incentives work, there are potential drawbacks.
Joel Saget/AFP via Getty Images
Millions of Americans say they won't get the vaccine. Will money change their minds? And is luring them with cash the right approach?
Tony Potts, a 69-year-old retiree, removes his face mask for a temperature check just before receiving his first injection in a phase 3 COVID-19 vaccine clinical trial sponsored by Moderna. Potts is one of 30,000 participants in the Moderna trial.
Paul Hennessy/NurPhoto via Getty ImageS
The vaccines that will first be used to prevent the spread of COVID-19 will have gone through a special approval process with the FDA. but just what is this expedited process?
Zoë McLaren, University of Maryland, Baltimore County
The new BinaxNOW antigen test is quick, easy, accurate and cheap. It could solve the US testing problem, but the emergency use authorization only allows people with COVID-19 symptoms to get tested.
FDA Commissioner Stephen Hahn, right, and President Trump at a Coronavirus Task Force meeting March 19, 2020.
Chip Somodevilla/Getty Images
The rushed emergency approval for a treatment that might help COVID-19 patients has raised questions: Is the FDA abandoning its own guidelines?
Ordinary food coloring suspended in tiny droplets in the air can generate oxygen free radicals that collide with airborne virus particles.
wwing/iStock/Getty Images Plus
Zoë McLaren, University of Maryland, Baltimore County
Testing large numbers of people regularly would reduce the spread of the coronavirus in the US. Laboratory testing is slow and expensive, but rapid screening tests could be the answer.
Corporate boards with women on them are more likely to recall dangerous products.
Image Source/Getty Images
The FDA has sped up its approval process for coronavirus treatments, creating a new division to expedite the regulatory process. But is safety being sidelined for speed?
Ticks can carry bacteria that causes Lyme Disease.
CDC via AP
Drugs and vaccines to fight the coronavirus are already in clinical trials. It is important to understand the difference between each step in this process as efforts to fight COVID-19 continue.
A coronavirus vaccine is coming, but when?
Francesco Carta fotografo/Moment via Getty Images
Vaccine development is usually a long process. The coronavirus pandemic is forcing researchers to innovate and test potential vaccines faster than ever before.
Testing in cells is an important and exciting first step.
elkor/E+ via Getty Images
Nevan Krogan, University of California, San Francisco
Researchers at the University of California, San Francisco, identified nine existing drugs that show promise to treat COVID-19. The proteins they target haven't been tried before.
Employees work on the production line of chloroquine phosphate, resumed after a 15-year break, in a pharmaceutical company in Nantong city in east China’s Jiangsu province Thursday, Feb. 27, 2020.
Feature China/Barcroft Media via Getty Images
Professor Emeritus of Health Policy and Management, York University, Emergency Physician at University Health Network, Associate Professor of Family and Community Medicine, University of Toronto
Professor and Director of Quantitative Biosciences Institute & Senior Investigator at the Gladstone Institutes, University of California, San Francisco